1. Glucose Restriction Promotes Osteocyte Specification by Activating a PGC-1α-Dependent Transcriptional Program
- Author
-
Sánchez-de-Diego, Cristina, Artigas, Natalia, Pimenta-Lopes, Carolina, Valer, José Antonio, Torrejon, Benjamin, Gama-Pérez, Pau, Villena, Josep A., Garcia-Roves, Pablo M., Rosa, José Luis, Ventura, Francesc, Universitat Autònoma de Barcelona, Institut Català de la Salut, [Sánchez-de-Diego C, Artigas N, Pimenta-Lopes C, Valer JA, Gama-Pérez P] Departament de Ciències Fisiològiques, Universitat de Barcelona, IDIBELL, L'Hospitalet de Llobregat, Spain. [Torrejon B] Centres Científics i Tecnològics, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain. [Villena JA] Laboratori de Metabolisme i Obesitat, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain., and Vall d'Hebron Barcelona Hospital Campus
- Subjects
0301 basic medicine ,Otros calificadores::/fisiología [Otros calificadores] ,Mitochondrial DNA ,células::células del tejido conectivo::osteoblastos::osteocitos [ANATOMÍA] ,Cèl·lules ,Cells ,Other subheadings::/physiology [Other subheadings] ,Other subheadings::Other subheadings::Other subheadings::/deficiency [Other subheadings] ,ADN mitocondrial ,02 engineering and technology ,Article ,Molecular Physiology ,03 medical and health sciences ,Cells::Connective Tissue Cells::Osteoblasts::Osteocytes [ANATOMY] ,Cell Physiological Phenomena::Cell Differentiation [PHENOMENA AND PROCESSES] ,Osteòcits - Fisiologia ,Bone cell ,Gene expression ,medicine ,lcsh:Science ,Gene ,hidratos de carbono::azúcares::monosacáridos::hexosas::glucosa [COMPUESTOS QUÍMICOS Y DROGAS] ,Multidisciplinary ,Chemistry ,AMPK ,Specialized Functions of Cells ,021001 nanoscience & nanotechnology ,medicine.disease ,fenómenos fisiológicos celulares::diferenciación celular [FENÓMENOS Y PROCESOS] ,Cell biology ,Osteopenia ,Malalties dels ossos ,Glucose ,030104 developmental biology ,medicine.anatomical_structure ,Carbohydrates::Sugars::Monosaccharides::Hexoses::Glucose [CHEMICALS AND DRUGS] ,Osteocyte ,Glucosa ,lcsh:Q ,Molecular Mechanism of Behavior ,Diferenciació cel·lular ,PPARGC1A ,Otros calificadores::Otros calificadores::Otros calificadores::/deficiencia [Otros calificadores] ,0210 nano-technology ,Bone diseases - Abstract
Summary Osteocytes, the most abundant of bone cells, differentiate while they remain buried within the bone matrix. This encasement limits their access to nutrients and likely affects their differentiation, a process that remains poorly defined. Here, we show that restriction in glucose supply promotes the osteocyte transcriptional program while also being associated with increased mitochondrial DNA levels. Glucose deprivation triggered the activation of the AMPK/PGC-1 pathway. AMPK and SIRT1 activators or PGC-1α overexpression are sufficient to enhance osteocyte gene expression in IDG-SW3 cells, murine primary osteoblasts, osteocytes, and organotypic/ex vivo bone cultures. Conversely, osteoblasts and osteocytes deficient in Ppargc1a and b were refractory to the effects of glucose restriction. Finally, conditional ablation of both genes in osteoblasts and osteocytes generate osteopenia and reduce osteocytic gene expression in mice. Altogether, we uncovered a role for PGC-1 in the regulation of osteocyte gene expression., Graphical Abstract, Highlights • Glucose restriction promotes osteocytic gene expression and mitochondrial function • Glucose restriction triggers activation of the AMPK/PGC-1 pathway • Effects of glucose restriction on osteocyte gene expression depend on Ppargc1a/b • Deletion of Ppargc1a/b in osteoblasts and osteocytes leads to osteopenia, Molecular Mechanism of Behavior; Molecular Physiology; Specialized Functions of Cells
- Published
- 2019
- Full Text
- View/download PDF